Localized Evolution, Opportunities, Challenges, and Development Pathways for Clinical Prevention in China

Abstract

Clinical prevention is the critical interface between individual clinical care and population-level public health. It is a strategic priority for the high-quality development of modern medicine and a fundamental requirement for promoting the modernization of the system and capacity for national governance. Drawing on the practical needs of the development of healthcare in China, this paper shows that clinical prevention in China has followed a localized trajectory defined by three enduring features: prevention first, a grassroots orientation, and the integration of traditional Chinese medicine (TCM) and Western medicine. In the new era, clinical prevention faces unprecedented historic opportunities created by national strategy, structural shifts in health demand, supportive healthcare payment mechanisms, deep integration of technological empowerment and innovation, as well as accelerated interdisciplinary collaboration and systemic innovation. However, these opportunities coexist with deep institutional constraints: operating mechanisms that are poorly matched to current needs, weak recognition of the value of prevention and incomplete incentives, bottlenecks in community-level integration of medical care and prevention, and a workforce whose skills have not kept pace. The paper therefore sets an overall orientation that places health first and seeks to construct a life-course health management system.It proposes a five-pillar strategic framework comprising full-chain linkage, targeted prevention and control, precise intervention, technological empowerment, and multi-stakeholder coordination—and translates the integrated prevention–treatment pathway into three operational models: opportunistic prevention embeded in encounters, continuous contracted services, and precision prevention and treatment for key populations. Institutional innovation, capacity building, social collaboration, and sustainable resourcing are required to create incentives for medicine–prevention integration, strengthen the service base, foster participatory health governance, and establish durable investment mechanisms. The aim is to make clinical prevention a genuine first line of defense for population health.

Keywords

clinical prevention / public health / clinical diagnosis and treatment / medicine-prevention integration / health management

Rights & permissions

The Author(s). Published by Higher Education Press.

Just Accepted

This article has successfully passed peer review and final editorial review, and will soon enter typesetting, proofreading and other publishing processes. The currently displayed version is the accepted final manuscript. The officially published version will be updated with format, DOI and citation information upon launch. We recommend that you pay attention to subsequent journal notifications and preferentially cite the officially published version. Thank you for your support and cooperation.